Stockreport
Philips Wins FDA 510(k) Clearance for AI Heart Valve Repair Solution [Yahoo! Finance]
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations: ir.edwards.com
for its advanced AI-enabled solution, EchoNavigator R5.0 with DeviceGuide, developed in collaboration with Edwards Lifesciences. The solution is designed to assist physicians during minimally invasive mitral valve repair procedures and provides real-time AI-based visualization and navigation inside the heart. This marks a major milestone in AI-driven intervention cardiology, allowing Philips to commercially deploy the solution in the U.S. healthcare market. A leaking mitral valve, known as mitral regurgitation, affects more than 35 million people globally and over 2 million in the United States. Minimally invasive transcatheter techniques such as M-TEER offer an alternative to open heart surgery in selective patient populations. The DeviceGuide system tracks the repair device inside the heart using AI, combines ultrasound and X-ray imaging into one unified view, and provides device trajectory, orientation guidance and real-time positioning feedback. DeviceGuide positions Philips to
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | EW | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
EW alerts
EW alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
NEWS
NEWS
- Marie O'Malley to Speak on Manufacturing Tradeoffs Panel at MPP West 2026[PR Web]
- A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market [Yahoo! Finance][Yahoo! Finance]
- Edwards Lifesciences (EW) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $92.00 price target on the stock.[MarketBeat]
- Boston Scientific: From Hypergrowth To Durable Compounding [Seeking Alpha][Seeking Alpha]
- Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits [Yahoo! Finance][Yahoo! Finance]
- More
EW
SEC Filings
SEC Filings
- 4/2/26 - Form 4
- 3/26/26 - Form SCHEDULE
- 3/26/26 - Form ARS
- EW's page on the SEC website
- More